Orreco Expands Portfolio with Acquisition of Jessica Ennis-Hill's Jennis Platform
In a significant move within the women's health and sports technology sector, AI bio-analytics platform Orreco has announced the acquisition of Jennis, the hormone health and performance platform founded by Olympic champion Dame Jessica Ennis-Hill. The deal represents a strategic expansion for Orreco, which is backed by prominent tech investor and Dallas Mavericks minority owner Mark Cuban.
Creating a Comprehensive Women's Performance Ecosystem
The acquisition brings Jennis into Orreco's growing portfolio of women-focused performance technologies, which already includes FitrWoman – a menstrual cycle tracking platform used by England's Lionesses football team – and DDSA Computer Vision, a biomechanical analysis firm employed by tennis star Aryna Sabalenka. According to Orreco, this combination will create what they describe as "the most advanced women's performance ecosystem in the world."
Ennis-Hill expressed her enthusiasm for the partnership, stating: "I'm really excited about the Orreco vision and success in the elite women's sports space. I'm delighted to join their team at this very exciting time to help open more conversations with sportswomen and teams."
Technological Integration and Strategic Vision
Orreco co-founder Dr Brian Moore emphasised that the acquisition represents more than just adding another tool to their collection. "This is not a collection of tools – it's a single intelligence platform," he explained. "By uniting Orreco AI with FitrWoman, Jennis IP and DDSA computer vision, we are redefining how women's performance is measured, understood and optimised."
The company's official statement outlined how the integration will work:
- Jennis contributes hormonal health intellectual property and expert training programmes
- FitrWoman adds menstrual-cycle intelligence capabilities
- DDSA Computer Vision provides biomechanical analysis technology
- Orreco's AI analytics platform serves as the unifying intelligence layer
Financial Backing and Industry Impact
The acquisition follows Orreco's recent $4 million Series A funding round, which was led by billionaire investor Mark Cuban. This financial backing has enabled the company to pursue strategic acquisitions like Jennis as it seeks to establish what it calls "a new global benchmark for female performance in elite sport, healthcare, and consumer wellbeing."
Ennis-Hill highlighted the potential impact on elite athletes, noting: "As an elite athlete every marginal gain is critical to be the best and with the incredible advances Orreco has made with their @thlete platform and the potential to apply this to their work with elite sportswomen, and teams is a game changer."
The deal represents a significant consolidation in the growing market for women's health and performance technology, bringing together complementary technologies under one AI-powered platform with substantial financial backing and high-profile athletic endorsement.
